CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases
Crossref DOI link: https://doi.org/10.1038/s41401-020-00510-6
Published Online: 2020-09-03
Published Print: 2020-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Xue-zhi
Wei, Wei
Text and Data Mining valid from 2020-09-03
Version of Record valid from 2020-09-03
Article History
Received: 12 May 2020
Accepted: 17 August 2020
First Online: 3 September 2020
Competing interests
: The authors declare no competing interests.